miR-21 regulates ischemic neuronal injury via the p53/Bcl-2/Bax signaling pathway

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Focal cerebral ischemia causes significant neuronal apoptosis, leading to cerebral infarction.
• MicroRNA-21 (miR-21) is recognized as a neuroprotective factor against ischemia, but its mechanism is unclear.
• Understanding miR-21's role is crucial for developing treatments for ischemic stroke.

Purpose of the Study:

• To elucidate the precise mechanism of miR-21 in ischemic neuroprotection.
• To investigate the relationship between miR-21 and p53 in the context of cerebral ischemia.
• To explore the therapeutic potential of the miR-21/p53 axis in ischemic stroke.

Main Methods:

• Investigated miR-21 and p53 expression levels in vitro and in vivo following ischemia.
• Manipulated miR-21 levels (overexpression and inhibition) to assess effects on p53 expression and neuronal injury.
• Analyzed the regulation of Bcl-2/Bax signaling pathway and its impact on neuronal apoptosis and ischemic damage.

Main Results:

• miR-21 was downregulated while p53 was upregulated post-ischemia.
• miR-21 overexpression inhibited p53, while miR-21 inhibition promoted p53 expression.
• The miR-21/p53 axis modulated Bcl-2/Bax expression, mitigating OGD/R-induced neuronal injury and improving outcomes in vivo.

Conclusions:

• miR-21 protects against cerebral ischemic neuronal injury by inhibiting the p53/Bcl-2/Bax signaling pathway.
• The miR-21/p53 axis represents a novel therapeutic target for ischemic stroke.
• Targeting miR-21/p53 may offer a promising strategy for neuroprotection and functional recovery after stroke.